1. Home
  2. CGEN vs MIMI Comparison

CGEN vs MIMI Comparison

Compare CGEN & MIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • MIMI
  • Stock Information
  • Founded
  • CGEN 1993
  • MIMI 2018
  • Country
  • CGEN Israel
  • MIMI Hong Kong
  • Employees
  • CGEN N/A
  • MIMI N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • MIMI
  • Sector
  • CGEN Health Care
  • MIMI
  • Exchange
  • CGEN Nasdaq
  • MIMI NYSE
  • Market Cap
  • CGEN 149.6M
  • MIMI 125.0M
  • IPO Year
  • CGEN 2000
  • MIMI 2025
  • Fundamental
  • Price
  • CGEN $1.56
  • MIMI $6.00
  • Analyst Decision
  • CGEN Strong Buy
  • MIMI
  • Analyst Count
  • CGEN 1
  • MIMI 0
  • Target Price
  • CGEN $4.00
  • MIMI N/A
  • AVG Volume (30 Days)
  • CGEN 299.7K
  • MIMI 141.7K
  • Earning Date
  • CGEN 03-04-2025
  • MIMI 01-01-0001
  • Dividend Yield
  • CGEN N/A
  • MIMI N/A
  • EPS Growth
  • CGEN N/A
  • MIMI N/A
  • EPS
  • CGEN N/A
  • MIMI 0.04
  • Revenue
  • CGEN $27,864,000.00
  • MIMI $4,382,996.00
  • Revenue This Year
  • CGEN $22.94
  • MIMI N/A
  • Revenue Next Year
  • CGEN $15.88
  • MIMI N/A
  • P/E Ratio
  • CGEN N/A
  • MIMI $161.37
  • Revenue Growth
  • CGEN N/A
  • MIMI 63.94
  • 52 Week Low
  • CGEN $1.35
  • MIMI $3.83
  • 52 Week High
  • CGEN $2.66
  • MIMI $6.84
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 38.91
  • MIMI N/A
  • Support Level
  • CGEN $1.54
  • MIMI N/A
  • Resistance Level
  • CGEN $1.64
  • MIMI N/A
  • Average True Range (ATR)
  • CGEN 0.08
  • MIMI 0.00
  • MACD
  • CGEN 0.01
  • MIMI 0.00
  • Stochastic Oscillator
  • CGEN 26.92
  • MIMI 0.00

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About MIMI MINT INCORPORATION LIMITED

Mint Inc Ltd is a Hong Kong-based interior design and fit-out works provider. It strategically focuses on providing integrated and industry-specific interior design and fit-out works for commercial properties. The company's work encompasses offices of different industries and various kinds of retail stores to reflect its customers' corporate values and conceptualize its customers' brands. Its commercial projects cover internationally-renowned retail stores, food and beverage outlet chains, offices, and other premises of a charitable organization in Hong Kong. It also provides integrated interior design and fit-out works for luxury residential properties to enhance the interior space's aesthetics and functionality.

Share on Social Networks: